Voyager Therapeutics Inc.

(VYGR) Trade

By |

Profile

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease. The company has developed products such as VY-AADC01 for Advanced Parkinson's Disease, VY-HTT01 for Huntington's Disease. Voyager's sole source of revenue is generated through its collaboration with a company called Genzyme. Genzyme funds the collaboration for the multiple gene therapy programs, including programs for Parkinson's disease, Friedreich's ataxia, and Huntington's disease, as well as other CNS disorders.

Contact Information

Website: www.voyagertherapeutics.com
Email: mosborne@vygr.com
Main Phone: +1 857 259-5340
Address: 75 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: G. Andre Turenne
Employees: 88
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 9.63 $ -0.17 (-1.73%)
Last Price 9.63 Change $ -0.17 Change % -1.73 Tick N/A
Bid N/A Bid Size 0.00 Ask 11.00 Ask Size 100.00
Open 9.90 High 9.91 Low 8.98 Prev Close 9.80
Last Trade Volume 813,203 52 Wk Hi 31.91 52 Wk Low 8.98
Market Cap 313.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,556,874.00 EPS (TTM) -2.43 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 9 23
Number of Buys 4 4
Number of Sells 5 19
Net Activity -2451 -86149
Last 10 Buys Shares
Steven M. Paul 1,000
Last 10 Sell Shares
Bernard Ravina 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Bernard Ravina 1,000
Dinah Sah 1,000
Bernard Ravina 1,000
Bernard Ravina 1,000
Bernard Ravina 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 43 43 43 43
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 32.22 32.5 32.5 32.22
Standard Deviation 7.36 7.82 7.82 7.36
Date of Most Recent Estimate 06/04/18 05/16/18 05/16/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 2 2 2 2
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.63 1.63